Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in EXEL — Exelixis, Inc.

CIK 886982 NEW YORK, NY
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$146,389,506
+$55,523,868 QoQ
Shares Held
2,690,489
+27.0% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#21
of 756 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Derivatives in EXEL

reported options exposure · as of Mar 31, 2021
CallValue
$284,634
CallShares
12,600
PutValue
$1,174,680
PutShares
52,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. EXEL ranks #20 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in EXEL

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $146,389,506 2,690,489
2026-03-31 $90,865,638 2,118,574
2025-12-31 $92,720,435 2,115,456
2025-09-30 $41,363,601 1,001,540
2025-06-30 $100,859,843 2,288,109
2024-12-31 $46,574,911 1,398,646
2024-09-30 $25,132,834 968,510
2024-06-30 $25,993,498 1,156,809
2024-03-31 $21,506,118 906,284
2023-12-31 $25,160,927 1,048,809
2023-09-30 $22,789,024 1,042,976
2023-06-30 $19,699,810 1,030,864
2023-03-31 $18,788,627 967,987
2022-12-31 $69,585,080 4,338,222
2022-09-30 $74,288,703 4,737,800
2022-06-30 $90,917,212 4,366,821
2022-03-31 $73,682,962 3,250,241
2021-12-31 $49,905,057 2,730,036
2021-09-30 $55,847,799 2,641,807
2021-06-30 $45,601,416 2,502,822
2021-03-31 $284,634 12,600
2021-03-31 $53,041,522 2,348,009
2021-03-31 $1,174,680 52,000
2020-12-31 $53,810,198 2,681,126
2020-09-30 $67,571,266 2,763,651
2020-06-30 $90,263,871 3,802,185
2020-06-30 $712,200 30,000
2020-06-30 $712,200 30,000
2020-03-31 $688,800 40,000
2020-03-31 $64,209,832 3,728,794